Antigens, Neoplasm

"Antigens, Neoplasm" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin.

Descriptor ID	D000951
MeSH Number(s)	D23.050.285
Concept/Terms	Antigens, Neoplasm Antigens, Neoplasm Neoplasm Antigens Tumor Antigens Tumor Antigens Antigens, Tumor

Below are MeSH descriptors whose meaning is more general than "Antigens, Neoplasm".

Chemicals and Drugs [D]
Biological Factors [D23]
Antigens [D23.050]
Antigens, Neoplasm [D23.050.285]

Below are MeSH descriptors whose meaning is related to "Antigens, Neoplasm".

Below are MeSH descriptors whose meaning is more specific than "Antigens, Neoplasm".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Antigens, Neoplasm" by people in this website by year, and whether "Antigens, Neoplasm" was a major or minor topic of these publications.

Bar chart showing 69 publications over 21 distinct years, with a maximum of 6 publications in 2006 and 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	1	0	1
2003	1	1	2
2004	2	1	3
2005	0	1	1
2006	4	2	6
2007	5	0	5
2008	4	1	5
2009	3	0	3
2010	2	1	3
2011	3	0	3
2012	2	1	3
2013	3	1	4
2014	5	0	5
2015	2	2	4
2016	4	2	6
2017	2	1	3
2018	1	1	2
2019	0	3	3
2020	1	1	2
2022	1	1	2
2025	2	1	3

Below are the most recent publications written about "Antigens, Neoplasm" by people in Profiles.

Akbari B, Hasan MM, Islam SM. Advances in targeted therapy for triple-negative breast cancer: a review of key antigens and recent advances. J Drug Target. 2025 Nov; 33(9):1555-1574.

View in: PubMed
Xiong Z, Sneiderman CT, Kuminkoski CR, Reinheimer J, Schwegman L, Sever RE, Habib A, Hu B, Agnihotri S, Rajasundaram D, Zinn PO, Forsthuber TG, Pollack IF, Li X, Raphael I, Kohanbash G. Transcript-targeted antigen mapping reveals the potential of POSTN splicing junction epitopes in glioblastoma immunotherapy. Genes Immun. 2025 Jun; 26(3):190-199.

View in: PubMed
Raphael I, Xiong Z, Sneiderman CT, Raphael RA, Mash M, Schwegman L, Jackson SA, O'Brien C, Anderson KJ, Sever RE, Hendrikse LD, Vincze SR, Diaz A, Felker J, Nazarian J, Nechemia-Arbely Y, Hu B, Kammula US, Agnihotri S, Rich JN, Broniscer A, Drappatz J, Abel TJ, Uttam S, Hwang EI, Pearce TM, Taylor MD, Nisnboym M, Forsthuber TG, Pollack IF, Chikina M, Rajasundaram D, Kohanbash G. The T cell receptor landscape of childhood brain tumors. Sci Transl Med. 2025 Mar 19; 17(790):eadp0675.

View in: PubMed
Ma Y, Qiu C, Wang B, Zhang X, Wang X, Aguilera RJ, Zhang JY. Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular Carcinoma. Cells. 2022 10 14; 11(20).

View in: PubMed
Beasley HK, Widatalla SE, Whalen DS, Williams SD, Korolkova OY, Namba C, Pratap S, Ochieng J, Sakwe AM. Identification of MAGEC2/CT10 as a High Calcium-Inducible Gene in Triple-Negative Breast Cancer. Front Endocrinol (Lausanne). 2022; 13:816598.

View in: PubMed
Principe N, Kidman J, Goh S, Tilsed CM, Fisher SA, Fear VS, Forbes CA, Zemek RM, Chopra A, Watson M, Dick IM, Boon L, Holt RA, Lake RA, Nowak AK, Lesterhuis WJ, McDonnell AM, Chee J. Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy. Front Immunol. 2020; 11:584423.

View in: PubMed
Taniguchi Y, Ishida M, Saito T, Ryota H, Utsumi T, Maru N, Matsui H, Hino H, Tsuta K, Murakawa T. Preferentially expressed antigen in melanoma as a novel diagnostic marker differentiating thymic squamous cell carcinoma from thymoma. Sci Rep. 2020 07 23; 10(1):12286.

View in: PubMed
Sneddon S, Rive CM, Ma S, Dick IM, Allcock RJN, Brown SD, Holt RA, Watson M, Leary S, Lee YCG, Robinson BWS, Creaney J. Identification of a CD8+ T-cell response to a predicted neoantigen in malignant mesothelioma. Oncoimmunology. 2020; 9(1):1684713.

View in: PubMed
Manichaikul A, Peres LC, Wang XQ, Barnard ME, Chyn D, Sheng X, Du Z, Tyrer J, Dennis J, Schwartz AG, Cote ML, Peters E, Moorman PG, Bondy M, Barnholtz-Sloan JS, Terry P, Alberg AJ, Bandera EV, Funkhouser E, Wu AH, Pearce CL, Pike M, Setiawan VW, Haiman CA, Palmer JR, LeMarchand L, Wilkens LR, Berchuck A, Doherty JA, Modugno F, Ness R, Moysich K, Karlan BY, Whittemore AS, McGuire V, Sieh W, Lawrenson K, Gayther S, Sellers TA, Pharoah P, Schildkraut JM. Identification of novel epithelial ovarian cancer loci in women of African ancestry. Int J Cancer. 2020 06 01; 146(11):2987-2998.

View in: PubMed
Majem B, Parrilla A, Jim?nez C, Su?rez-Cabrera L, Barber M, Mar?n A, Castellv? J, Tamayo G, Moreno-Bueno G, Ponce J, Matias-Guiu X, Alameda F, Romero I, S?nchez JL, P?rez-Benavente A, Moran S, Esteller M, Revent?s J, Rigau M, Gil-Moreno A, Segura MF, Santamar?a A. MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways. Oncogene. 2019 08; 38(32):6035-6050.

View in: PubMed

People

Explore

Similar Concepts

Top Journals